HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Shyr Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2017Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial.
8/2004Nuclear survivin as a biomarker for non-small-cell lung cancer.
12/2001Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.
1/2001Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
1/2001A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy.
7/2000A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
4/2000A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Shyr Research Topics

Disease

18Neoplasms (Cancer)
01/2021 - 04/2000
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 04/2000
4Carcinoma (Carcinomatosis)
02/2001 - 03/2000
3Breast Neoplasms (Breast Cancer)
03/2004 - 04/2000
2Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 07/2001
2Esophagitis
12/2001 - 04/2000
2Pain (Aches)
05/2001 - 03/2000
2Pneumonia (Pneumonitis)
01/2001 - 03/2000
1Obesity
01/2021
1Diabetes Mellitus
01/2021
1COVID-19
01/2021
1Neoplasm Metastasis (Metastasis)
05/2014
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2012
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2010
1Squamous Cell Carcinoma of Head and Neck
04/2010
1Uremia
09/2002
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2002
1Inflammation (Inflammations)
09/2002
1Gingival Recession
10/2001
1Critical Illness (Critically Ill)
10/2001
1Malnutrition (Nutritional Deficiencies)
10/2001
1Acute Kidney Injury (Acute Renal Failure)
10/2001
1Thrombosis (Thrombus)
09/2001
1Carcinogenesis
07/2001
1Hepatocellular Carcinoma (Hepatoma)
07/2001
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2001
1Head and Neck Neoplasms (Head and Neck Cancer)
07/2001
1Postoperative Pain
05/2001
1Gastritis
03/2001
1Acute Lung Injury
01/2001
1Lung Injury
01/2001
1Appendicitis
10/2000

Drug/Important Bio-Agent (IBA)

5Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 03/2000
4Carboplatin (JM8)FDA LinkGeneric
01/2017 - 03/2000
4Docetaxel (Taxotere)FDA Link
04/2010 - 04/2000
3CytokinesIBA
05/2014 - 08/2000
2Etoposide (VP 16)FDA LinkGeneric
01/2017 - 03/2000
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 01/2001
2CollagenIBA
10/2001 - 07/2000
2Irinotecan (Camptosar)FDA LinkGeneric
07/2001 - 01/2001
2Protein Isoforms (Isoforms)IBA
06/2001 - 07/2000
2Fluorouracil (Carac)FDA LinkGeneric
01/2001 - 07/2000
2Leucovorin (Folinic Acid)FDA Link
01/2001 - 07/2000
2Contrast MediaIBA
10/2000 - 06/2000
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1CreatinineIBA
01/2021
1C-Reactive ProteinIBA
01/2021
1TroponinIBA
01/2021
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2014
1Phosphotransferases (Kinase)IBA
05/2014
1Protein Phosphatase 2CIBA
05/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2014
1Interleukin-6 (Interleukin 6)IBA
05/2014
1Rituximab (Mabthera)FDA Link
01/2012
1DNA (Deoxyribonucleic Acid)IBA
12/2010
1Focal Adhesion Protein-Tyrosine KinasesIBA
12/2010
1NF-kappa B (NF-kB)IBA
04/2010
1ErbB Receptors (EGF Receptor)IBA
04/2010
1Bortezomib (Velcade)FDA Link
04/2010
1antineoplaston A10 (A 10)IBA
02/2008
1CarcinogensIBA
02/2008
1SurvivinIBA
08/2004
1Biomarkers (Surrogate Marker)IBA
08/2004
1Trastuzumab (Herceptin)FDA Link
03/2004
1Oxidants (Oxidizing Agents)IBA
09/2002
1Complement System Proteins (Complement)IBA
09/2002
1Insulin (Novolin)FDA Link
09/2002
1Insulin-Like PeptidesIBA
10/2001
1NitrogenIBA
10/2001
1Prealbumin (Transthyretin)IBA
10/2001
1Serum AlbuminIBA
10/2001
1Human Growth Hormone (Saizen)FDA LinkGeneric
10/2001
1Oxygen (Dioxygen)IBA
09/2001
1Polytetrafluoroethylene (Teflon)FDA Link
09/2001
1efaproxiral (RSR-13)IBA
09/2001
1Hemoglobins (Hemoglobin)IBA
09/2001
1Cyclin D1IBA
07/2001
19-aminocamptothecinIBA
07/2001
1Topotecan (Hycamtin)FDA LinkGeneric
07/2001
1Topoisomerase I InhibitorsIBA
07/2001
1oltiprazIBA
06/2001
1AflatoxinsIBA
06/2001
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
06/2001
1Morphine (MS Contin)FDA LinkGeneric
05/2001
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2001
1AntralIBA
03/2001
1irofulvenIBA
01/2001
1Antineoplastic Agents (Antineoplastics)IBA
01/2001
1Vitamin EFDA LinkGeneric
01/2001

Therapy/Procedure

7Therapeutics
01/2021 - 04/2000
6Drug Therapy (Chemotherapy)
01/2021 - 03/2000
6Radiotherapy
01/2017 - 03/2000
2Renal Dialysis (Hemodialysis)
09/2002 - 10/2000
2Catheters
09/2001 - 03/2000
1Critical Care (Surgical Intensive Care)
10/2001
1Thrombectomy
09/2001
1Microelectrodes
09/2001
1Intra-Articular Injections
05/2001
1Anterior Cruciate Ligament Reconstruction
05/2001
1Cryosurgery
01/2001